StabiLux Biosciences

Ann Arbor, MI · Founded 2014 · Privately Held (backing)

Developer of high-brightness fluorophores designed to improve the reagents that run through flow cytometers. StabiLux Biosciences is based in Ann Arbor, MI and was founded in 2014. It has raised $1.9 million across 1 recorded round; the latest was a $554,381 seed round in Apr 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$1.9M
Last round
Seed Round
Apr 2024
Cap table — not yet on record

StabiLux Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of StabiLux Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch StabiLux Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about StabiLux Biosciences

Where does StabiLux Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across StabiLux Biosciences's 1 recorded funding rounds.